Patents by Inventor Richard A. Gibbs
Richard A. Gibbs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20040156680Abstract: A device and method for stabilization of beaches and building walls, patios and similar simple structures consisting of blocks with trapezoidal or rectangular shapes which have staking or interlocking means of interconnecting blocks and where the top has an open area allowing fill by slurries of water and sand, gravel or clay and the escape of clarified water during and after filling.Type: ApplicationFiled: February 8, 2003Publication date: August 12, 2004Inventor: Richard A. Gibbs
-
Publication number: 20040121985Abstract: Farnesyl diphosphate analogs, specifically the 3-substituted alcohol precursors of the diphosphate analogs, 3-allylfarnesol and 3-vinylfarnesol, are potent inhibitors of mammalian protein fanesyltransferase (FTase). 3-allylgeranylgeraniol is a highly specific cellular inhibitor of protein geranylgeranylation (GGTase I). Furthermore, these compounds are able to efficiently block the anchorage-dependent growth of ras transformed cells. While 3-allylfarnesol inhibits protein farnesylation in situ, 3-vinylfarnesol instead leads to the abnormal prenylation of proteins with the 3-vinylfarnesyl group. In a similar manner, treatment with 3-allylgeranylgeraniol inhibits protein geranylgeranylation while 3-vinylgeranylgeraniol restores protein geranylgeranylation in cells.Type: ApplicationFiled: June 10, 2003Publication date: June 24, 2004Inventor: Richard A. Gibbs
-
Patent number: 6721419Abstract: A method and system for selecting a frequency for communication within a premises network are disclosed that offer significant operational advantages. According to one aspect of the present invention, a system for selecting a frequency for communication within a premises network may include a telephone line interface, a transceiver, and a logic/control unit coupled to both the telephone line interface and the transceiver. The telephone line interface may be operable to couple to a premises network. In some embodiments, the logic/control unit may be operable to select a first channel. The first channel may correspond to a first frequency over which communications may be sent from the transceiver to other devices within the premises network.Type: GrantFiled: June 8, 2000Date of Patent: April 13, 2004Assignee: PremiseNET IncorporatedInventors: Larry A. Stell, Richard A. Gibbs, Bernard F. Bareis, Gerry A. Parker, Francis M. Sharp, Michael Gosha
-
Patent number: 6586461Abstract: Farnesyl diphosphate analogs, specifically the 3-substituted alcohol precursors of the diphosphate analogs, 3-allylfarnesol and 3-vinylfarnesol, are potent inhibitors of mammalian protein fanesyltransferase (FTase). 3-allylgeranylgeraniol is a highly specific cellular inhibitor of protein geranylgeranylation (GGTase I). Furthermore, these compounds are able to efficiently block the anchorage-dependent growth of ras transformed cells. While 3-allylfarnesol inhibits protein farnesylation in situ, 3-vinylfarnesol instead leads to the abnormal prenylation of proteins with the 3-vinylfarnesyl group. In a similar manner, treatment with 3-allylgeranylgeraniol inhibits protein geranylgeranylation while 3-vinylgeranylgeraniol restores protein geranylgeranylation in cells.Type: GrantFiled: June 16, 1999Date of Patent: July 1, 2003Assignee: Wayne State UniversityInventor: Richard A. Gibbs
-
Patent number: 6349133Abstract: A method and system interface a digital data stream having at least one telephony data set with a telephony network, such as a single twisted wire pair telephony network installed in a residence or business. The telephony data set is converted to a telephony signal for use by conventional telephony devices, such as telephones, and is transmitted through the telephony network in a telephony network band. The telephony network band can be located outside of the voiceband to avoid interference with central office signals. Plural data telephony data sets can each provide a telephony signal directed to one or more telephony devices associated with the telephony network. Telephone control modules interfaced associated with the telephony devices can translate telephony signals from the telephony network band to the voiceband for use by the associated telephony devices. The method and system can support plural simultaneous telephony communications through a single twisted pair or other telephony network.Type: GrantFiled: April 15, 1998Date of Patent: February 19, 2002Assignee: Premisenet IncorporatedInventors: Gordon H. Matthews, Larry A. Stell, Richard A. Gibbs, Martin L. Herring, Patrick Koons, Robert H. Frantz
-
Patent number: 5994063Abstract: The use of BODIPY.RTM. fluorophores for detecting a target nucleic acid is described. The parent heterocyclic molecule of the BODIPY.RTM. fluorophores is a dipyrrometheneboron difluoride compound which is modified to create a broad class of spectrally-discriminating fluorophores. The present invention provides oligonucleotides labelled with substituted 4,4-difluoro-4-bora-3A,4A-diaza-s-indacene (BODIPY.RTM. fluorophore) compounds for performing the Taqman assay.Type: GrantFiled: March 7, 1996Date of Patent: November 30, 1999Inventors: Michael L. Metzker, Richard A. Gibbs
-
Patent number: 5861287Abstract: Methods for the use of a class of dyes for improved DNA sequencing are provided. A new class of dyes, BODIPY.RTM. fluorophores, has been described recently. The parent heterocyclic molecule of the BODIPY.RTM. fluorophores is a dipyrrometheneboron difluoride compound which is modified to create a broad class of spectrally-discriminating fluorophores. The present invention provides methods for the use of BODIPY.RTM. fluorophore-labeled DNA for dye-primer sequencing in which the BODIPY.RTM.s are attached to the 5' end of sequencing primers. BODIPY.RTM. fluorophores have improved spectral characteristics compared to conventional fluorescein and rhodamine dyes. BODIPY.RTM. fluorophores have narrower band width, insensitivity to solvent or pH, and improved photostability, thus, BODIPY.RTM. fluorophores lead to improved DNA sequencing and/or detection in any method where electrophoresis and detection of DNA is required. Additionally, the spectral properties of the BODIPY.RTM.Type: GrantFiled: October 6, 1995Date of Patent: January 19, 1999Assignee: Baylor College of MedicineInventors: Michael L. Metzker, Richard A. Gibbs
-
Patent number: 5728529Abstract: Methods for the use of a class of dyes for improved DNA sequencing by the chain termination method of DNA sequencing, and internal labelling of polynucleotides by enzymatic incorporation of fluorescently-labeled ribonucleotides or deoxyribonucleotides are provided. A new class of dyes, BODIPY.RTM. fluorophores, has been described recently. The parent heterocyclic molecule of the BODIPY.RTM. fluorophores is a dipyrrometheneboron difluoride compound which is modified to create a broad class of spectrally-discriminating fluorophores. BODIPY.RTM. fluorophores have improved spectral characteristics compared to conventional fluorescein and rhodamine dyes. BODIPY.RTM. fluorophores have narrower band width, insensitivity to solvent or pH, and improved photostability, thus, BODIPY.RTM. fluorophores lead to improved DNA sequencing and/or detection in any method where electrophoresis and detection of DNA is required. Additionally, the spectral properties of the BODIPY.RTM.Type: GrantFiled: November 6, 1995Date of Patent: March 17, 1998Assignee: Baylor College Of MedicineInventors: Michael L. Metzker, Richard A. Gibbs
-
Patent number: 5614386Abstract: Methods for the use of a class of dyes for improved DNA sequencing are provided. A new class of dyes, BODIPY.RTM. fluorophore, has been described recently. The parent heterocyclic molecule of the BODIPY.RTM. fluorophore is a dipyrrometheneboron difluoride compound which is modified to create a broad class of spectrally-discriminating fluorophores. The present invention provides methods for the use of BODIPY.RTM. fluorophore-labeled DNA. BODIPY.RTM. fluorophore have improved spectral characteristics compared to conventional fluorescein and rhodamine dyes. BODIPY.RTM. fluorophore have narrower band width, insensitivity to solvent or pH, and improved photostability, thus, BODIPY.RTM. fluorophores lead to improved DNA sequencing and/or detection in any method where electrophoresis and detection of DNA is required. Additionally, the spectral properties of the BODIPY.RTM. fluorophores are sufficiently similar in wavelength and intensity to be used with conventional equipment known in the art.Type: GrantFiled: June 23, 1995Date of Patent: March 25, 1997Assignee: Baylor College of MedicineInventors: Michael L. Metzker, Richard A. Gibbs
-
Patent number: 5469503Abstract: In an automatic call distribution (ACD) system having a controller function, a primary system controller and a redundant system controller wherein the secondary system controller is in active operation and the primary system controller is out of synchronization with the redundant system controller, a method is provided for resynchronizing the primary system controller to the redundant system controller wherein selected database update functionality of the redundant system controller is suspended and database files and shared memory are copied in phases from the redundant system controller to the primary system controller with the means provided to continue to do data collection, call answering and queuing of calls, except for a brief period immediately preceding resynchronization.Type: GrantFiled: October 14, 1993Date of Patent: November 21, 1995Assignee: Aspect Telecommunications CorporationInventors: Michael J. Butensky, Richard A. Gibbs, Kevin T. Collins, Yih-Nan Yang, Eric M. Johnson, Chris A. Grafft
-
Patent number: 5439812Abstract: A hapten is described which may be used to elicit antibodies that catalyze the deamidation of asparginyl-glycyl dipeptides to form two products, the isoaspartyl-glycyl dipeptide and the aspartyl-glycyl dipeptide. A general synthetic scheme is also presented which shows how to modify the hapten to provide specificity for a particular protein in the antibodies that are elicited by the (modified) hapten. Antibodies which catalyze the the deamidation reaction are also described.Type: GrantFiled: April 8, 1992Date of Patent: August 8, 1995Assignee: The Pennsylvania Research CorporationInventors: Stephen J. Benkovic, Scott D. Taylor, Richard A. Gibbs